162 related articles for article (PubMed ID: 12516194)
21. Resistant pneumococci: a renewed threat in respiratory infections.
Goldstein FW; Garau J
Scand J Infect Dis Suppl; 1994; 93():55-62. PubMed ID: 8047858
[TBL] [Abstract][Full Text] [Related]
22. Epidemiology of antibiotic-resistant Streptococcus pneumoniae strains in Far East Russia.
Martynova AV; Turcutyuicov VB
Int J Antimicrob Agents; 2004 Jun; 23(6):641-2. PubMed ID: 15194139
[No Abstract] [Full Text] [Related]
23. Mechanisms, molecular and sero-epidemiology of antimicrobial resistance in bacterial respiratory pathogens isolated from Japanese children.
Sunakawa K; Farrell DJ
Ann Clin Microbiol Antimicrob; 2007 Aug; 6():7. PubMed ID: 17697316
[TBL] [Abstract][Full Text] [Related]
24. Problems in the management of penicillin-resistant pneumococci.
Boswell TC; Smith EG; Ayres JG
J Hosp Infect; 1995 Jul; 30(3):233-5. PubMed ID: 8522781
[No Abstract] [Full Text] [Related]
25. Penicillin and macrolide resistance in pneumococcal pneumonia: does in vitro resistance affect clinical outcomes?
Rothermel CD
Clin Infect Dis; 2004 May; 38 Suppl 4():S346-9. PubMed ID: 15127368
[TBL] [Abstract][Full Text] [Related]
26. Resisting the urge to prescribe.
Edwards KM
J Pediatr; 1996 Jun; 128(6):729-30. PubMed ID: 8648528
[No Abstract] [Full Text] [Related]
27. [Antibiotic therapy for community acquired Streptococcus pneumoniae pneumonia: clinical relevance of antibiotic resistance].
Bédos JP; Bruneel F
Med Mal Infect; 2006; 36(11-12):667-79. PubMed ID: 16842956
[TBL] [Abstract][Full Text] [Related]
28. [Epidemiological study on patients with pneumococcal respiratory tract infection in a Japanese health facility during the past year].
Odagiri S; Watanuki Y; Takahashi H; Shimada J
Jpn J Antibiot; 2001 May; 54 Suppl B():22-4; discussion 25-7. PubMed ID: 12638138
[No Abstract] [Full Text] [Related]
29. Antibiotic resistance patterns and serotype distribution in Streptococcus pneumoniae from hospitalized pediatric patients with respiratory infections in Suzhou, China.
Chen R; Chen Y; Black S; Hao CL; Ding YF; Zhang T; Zhao GM
J Trop Pediatr; 2010 Jun; 56(3):204-5. PubMed ID: 19748932
[No Abstract] [Full Text] [Related]
30. Significance of macrolide resistance in Streptococcus pneumoniae.
Nuermberger EL; Bishai WR
J Antimicrob Chemother; 2003 Sep; 52(3):524-5; author reply 525. PubMed ID: 12888594
[No Abstract] [Full Text] [Related]
31. Increase in pneumococcus macrolide resistance, USA.
Hicks LA; Monnet DL; Roberts RM
Emerg Infect Dis; 2010 May; 16(5):896-7. PubMed ID: 20409403
[No Abstract] [Full Text] [Related]
32. New fluoroquinolones in lower respiratory tract infections and emerging patterns of pneumococcal resistance.
Ferrara AM
Infection; 2005 Jun; 33(3):106-14. PubMed ID: 15940410
[TBL] [Abstract][Full Text] [Related]
33. [Resistance of infectious agents involved in low respiratory tract infections in France].
Varon E; Houssaye S
Med Mal Infect; 2006; 36(11-12):555-69. PubMed ID: 16962730
[TBL] [Abstract][Full Text] [Related]
34. Streptococcus pneumoniae respiratory tract infections.
Klugman KP; Feldman C
Curr Opin Infect Dis; 2001 Apr; 14(2):173-9. PubMed ID: 11979129
[TBL] [Abstract][Full Text] [Related]
35. A fresh look at the definition of susceptibility of Streptococcus pneumoniae to beta-lactam antibiotics.
Musher DM; Bartlett JG; Doern GV
Arch Intern Med; 2001 Nov; 161(21):2538-44. PubMed ID: 11718584
[TBL] [Abstract][Full Text] [Related]
36. Antimicrobial susceptibilities and distribution of resistance genes for beta-lactams and macrolides in Streptococcus pneumoniae isolated between 2002 and 2004 in Tokyo.
Noguchi N; Tano J; Nasu Y; Koyama M; Narui K; Kamishima H; Saito T; Tsuyuki K; Sasatsu M
Int J Antimicrob Agents; 2007 Jan; 29(1):26-33. PubMed ID: 17189091
[TBL] [Abstract][Full Text] [Related]
37. Pneumococcal resistance: the treatment challenge.
Amsden GW; Amankwa K
Ann Pharmacother; 2001 Apr; 35(4):480-8. PubMed ID: 11302413
[TBL] [Abstract][Full Text] [Related]
38. Antimicrobial resistance of respiratory pathogens isolated from pediatric patients.
Zarakolu P; Unal S
J Chemother; 2006 Oct; 18(5):565-6. PubMed ID: 17127238
[No Abstract] [Full Text] [Related]
39. Bacterial resistance in the new millennium. Its impact on antibiotic selection for respiratory tract infections.
Appelbaum PC
Postgrad Med; 2000 Dec; 108(7 Suppl Contemporaty):5-16. PubMed ID: 19667544
[TBL] [Abstract][Full Text] [Related]
40. The efficacy of cefditoren pivoxil in the treatment of lower respiratory tract infections, with a focus on the per-pathogen bacteriologic response in infections caused by Streptococcus pneumoniae and Haemophilus influenzae: a pooled analysis of seven clinical trials.
Granizo JJ; Giménez MJ; Barberán J; Coronel P; Gimeno M; Aguilar L
Clin Ther; 2006 Dec; 28(12):2061-9. PubMed ID: 17296462
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
